US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Telomir Pharmaceuticals Inc (TELO)
Telomir Pharmaceuticals Inc (TELO) ニュース

TELO

Telomir Pharmaceuticals (TELO)

Telomir Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TELO

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/18	05 : 10	GlobeNewswire Inc.	Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/05/30	21 : 30	GlobeNewswire Inc.	Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/05/24	22 : 30	GlobeNewswire Inc.	New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ET	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/05/16	22 : 30	GlobeNewswire Inc.	Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/05/14	05 : 31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/04/16	21 : 30	GlobeNewswire Inc.	Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/04/02	21 : 30	GlobeNewswire Inc.	Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/03/30	05 : 44	GlobeNewswire Inc.	UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/03/26	21 : 30	GlobeNewswire Inc.	Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/03/22	21 : 30	GlobeNewswire Inc.	Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/03/14	21 : 30	GlobeNewswire Inc.	Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal Science	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/03/07	22 : 30	GlobeNewswire Inc.	Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conference	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/03/05	22 : 30	GlobeNewswire Inc.	Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal	NASDAQ:TELO	Telomir Pharmaceuticals Inc
2024/02/14	06 : 05	GlobeNewswire Inc.	Telomir Pharmaceuticals Announces Closing of Initial Public Offering	NASDAQ:TELO	Telomir Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:TELO

1

BNP Paribas Issuance

WisdomTree Silver 3x Dai...

Cshg Logistica Fundo Inv...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約